
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Despite two decades of warnings and education, not only do millions of Americans worship the sun at this time of year, some people can't get enough of it and are taking their desires for a deeper, darker tan a step further.